Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: Hypertension. 2010 Jan 11;55(2):284–290. doi: 10.1161/HYPERTENSIONAHA.109.146605

Figure 3.

Figure 3

Summary data of lumbar SNA, mean ABP and blood glucose during RVLM microinjection of KYN (∇) in rats receiving a hyperinsulinemic-euglycemic clamp (●, n=5) or saline infusion (□, n=5). Injection of KYN significantly reduced lumbar SNA in rats receiving a hyperinsulinemic clamp but had no effect in those receiving saline infusion. *Significant difference vs saline infused-rats (P<0.05), †Significant difference vs pre-injection or 90-min value (P<0.05).